Literature DB >> 21128024

The association of pituitary tumors and headache.

Miles J Levy1.   

Abstract

Pituitary tumors may give rise to headache via numerous mechanisms. The traditional explanation for headache is dural stretch and cavernous sinus invasion, although this is not borne out by clinical studies. Certain functional pituitary tumors are associated with headache, notably growth hormone and prolactin-secreting tumors. The observation that somatostatin analogues can have a dramatic analgesic effect in acromegaly suggests that biochemical properties of the tumor may be important. The genetic predisposition of the patient to primary headache also determines whether headache occurs with pituitary tumors. This article attempts to outline the clinical features, management strategies, and key academic questions regarding the subject of pituitary tumors and headache.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21128024     DOI: 10.1007/s11910-010-0166-7

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  50 in total

1.  Headache associated with pituitary adenomas.

Authors:  T Abe; K Matsumoto; J Kuwazawa; I Toyoda; K Sasaki
Journal:  Headache       Date:  1998 Nov-Dec       Impact factor: 5.887

2.  Immunohistochemical localization of the somatostatin SST2(A) receptor in the rat brain and spinal cord.

Authors:  M Schindler; L A Sellers; P P Humphrey; P C Emson
Journal:  Neuroscience       Date:  1997-01       Impact factor: 3.590

3.  Pituitary adenoma presenting as facial pain: report of two cases and review of the literature.

Authors:  A H Friedman; R H Wilkins; P D Kenan; C W Olanow; P J Dubois
Journal:  Neurosurgery       Date:  1982-06       Impact factor: 4.654

4.  Invasive adenoma of the pituitary gland and chronic migrainous neuralgia. A rare coincidence or a causal relationship?

Authors:  P Tfelt-Hansen; O B Paulson; A A Krabbe
Journal:  Cephalalgia       Date:  1982-03       Impact factor: 6.292

5.  Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.

Authors:  I Shimon; X Yan; J E Taylor; M H Weiss; M D Culler; S Melmed
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

6.  Effectiveness of slow-release lanreotide in previously operated and untreated patients with GH-secreting pituitary macroadenoma.

Authors:  S Cannavò; S Squadrito; L Curtò; B Almoto; F Trimarchi
Journal:  Horm Metab Res       Date:  2001-10       Impact factor: 2.936

7.  Pituitary volume and headache: size is not everything.

Authors:  Miles J Levy; H Rolf Jäger; Michael Powell; Manjit S Matharu; Karim Meeran; Peter J Goadsby
Journal:  Arch Neurol       Date:  2004-05

8.  Incidental pituitary macroadenoma: a population-based study.

Authors:  G M Nammour; J Ybarra; M H Naheedy; J H Romeo; D C Aron
Journal:  Am J Med Sci       Date:  1997-11       Impact factor: 2.378

9.  Inter- and intra-observer variability in detection and progression assessment with MRI of microadenoma in Cushing's disease patients followed up after bilateral adrenalectomy.

Authors:  Hélène Bahurel-Barrera; Guillaume Assie; Stéphane Silvera; Xavier Bertagna; Joël Coste; Paul Legmann
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 10.  Guidelines for acromegaly management: an update.

Authors:  S Melmed; A Colao; A Barkan; M Molitch; A B Grossman; D Kleinberg; D Clemmons; P Chanson; E Laws; J Schlechte; M L Vance; K Ho; A Giustina
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958

View more
  5 in total

1.  Presence of headache and headache types in patients with tumors of the sellar region-can surgery solve the problem? Results of a prospective single center study.

Authors:  Sonja Siegel; Renata Weber Carneiro; Michael Buchfelder; Bernadette Kleist; Agnieszka Grzywotz; Rolf Buslei; Ulrike Bingel; Georg Brabant; Thomas Schenk; Ilonka Kreitschmann-Andermahr
Journal:  Endocrine       Date:  2017-02-27       Impact factor: 3.633

Review 2.  How to investigate and treat: headache and hyperprolactinemia.

Authors:  Gennaro Bussone; Susanna Usai; Franca Moschiano
Journal:  Curr Pain Headache Rep       Date:  2012-08

Review 3.  Clinical Presentation and Management of Headache in Pituitary Tumors.

Authors:  Himanshu Suri; Carrie Dougherty
Journal:  Curr Pain Headache Rep       Date:  2018-06-15

Review 4.  Challenges in the diagnosis and management of acromegaly: a focus on comorbidities.

Authors:  Alin Abreu; Alejandro Pinzón Tovar; Rafael Castellanos; Alex Valenzuela; Claudia Milena Gómez Giraldo; Alejandro Castellanos Pinedo; Doly Pantoja Guerrero; Carlos Alfonso Builes Barrera; Humberto Ignacio Franco; Antônio Ribeiro-Oliveira; Lucio Vilar; Raquel S Jallad; Felipe Gaia Duarte; Mônica Gadelha; Cesar Luiz Boguszewski; Julio Abucham; Luciana A Naves; Nina Rosa C Musolino; Maria Estela Justamante de Faria; Ciliana Rossato; Marcello D Bronstein
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

Review 5.  Paroxysmal Hemicrania.

Authors:  Chinar Osman; Anish Bahra
Journal:  Ann Indian Acad Neurol       Date:  2018-04       Impact factor: 1.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.